Brind.

Neuronetics announced a collaboration agreement with Compass, leading to the FDA clearance of Spravato and the acquisition of Greenbrook TMS.

1 report, 1 independent Updated Jul 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Neuronetics announced a collaboration agreement with Compass, leading to the FDA clearance of Spravato and the acquisition of Greenbrook TMS.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped